Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Hepatic actions of androgens in the regulation of metabolism.

Birzniece V.

Curr Opin Endocrinol Diabetes Obes. 2018 Jun;25(3):201-208. doi: 10.1097/MED.0000000000000405.

PMID:
29373481
2.

Decorin, a growth hormone-regulated protein in humans.

Bahl N, Stone G, McLean M, Ho KKY, Birzniece V.

Eur J Endocrinol. 2018 Feb;178(2):147-154. doi: 10.1530/EJE-17-0844. Epub 2017 Nov 14.

PMID:
29138241
3.

Plasma biomarker proteins for detection of human growth hormone administration in athletes.

Tan SH, Lee A, Pascovici D, Care N, Birzniece V, Ho K, Molloy MP, Khan A.

Sci Rep. 2017 Aug 30;7(1):10039. doi: 10.1038/s41598-017-09968-7.

4.

Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis development.

Birzniece V, Barrett PHR, Ho KKY.

Eur J Endocrinol. 2017 Aug;177(2):137-143. doi: 10.1530/EJE-17-0151. Epub 2017 May 12.

PMID:
28500244
5.

Sex steroids and the GH axis: Implications for the management of hypopituitarism.

Birzniece V, Ho KKY.

Best Pract Res Clin Endocrinol Metab. 2017 Feb;31(1):59-69. doi: 10.1016/j.beem.2017.03.003. Epub 2017 Mar 14. Review.

PMID:
28477733
6.

Testosterone prevents protein loss via the hepatic urea cycle in human.

Lam T, Poljak A, McLean M, Bahl N, Ho KK, Birzniece V.

Eur J Endocrinol. 2017 Apr;176(4):489-496. doi: 10.1530/EJE-16-0868. Epub 2017 Jan 25.

PMID:
28122810
7.
8.

Formoterol, a highly β2-selective agonist, induces gender-dimorphic whole body leucine metabolism in humans.

Lee P, Birzniece V, Umpleby AM, Poljak A, Ho KK.

Metabolism. 2015 Apr;64(4):506-12. doi: 10.1016/j.metabol.2014.12.005. Epub 2014 Dec 26.

PMID:
25650070
9.

Doping in sport: effects, harm and misconceptions.

Birzniece V.

Intern Med J. 2015 Mar;45(3):239-48. doi: 10.1111/imj.12629. Review.

PMID:
25369881
10.

A critical evaluation of bioimpedance spectroscopy analysis in estimating body composition during GH treatment: comparison with bromide dilution and dual X-ray absorptiometry.

Birzniece V, Khaw CH, Nelson AE, Meinhardt U, Ho KK.

Eur J Endocrinol. 2015 Jan;172(1):21-8. doi: 10.1530/EJE-14-0660. Epub 2014 Oct 17.

PMID:
25326135
11.

Gonadal steroids and body composition, strength, and sexual function in men.

Birzniece V.

N Engl J Med. 2013 Dec 19;369(25):2455. doi: 10.1056/NEJMc1313169. No abstract available.

PMID:
24350955
12.

Effects of raloxifene and estrogen on bioactive IGF1 in GH-deficient women.

Birzniece V, Magnusson NE, Ho KK, Frystyk J.

Eur J Endocrinol. 2014 Feb 4;170(3):375-83. doi: 10.1530/EJE-13-0835. Print 2014 Mar.

PMID:
24347426
13.

Oral low-dose testosterone administration induces whole-body protein anabolism in postmenopausal women: a novel liver-targeted therapy.

Birzniece V, Umpleby MA, Poljak A, Handelsman DJ, Ho KK.

Eur J Endocrinol. 2013 Jul 29;169(3):321-7. doi: 10.1530/EJE-13-0406. Print 2013 Sep.

PMID:
23832866
14.

Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.

Birzniece V, Sutanto S, Ho KK.

J Clin Endocrinol Metab. 2012 Apr;97(4):E521-7. doi: 10.1210/jc.2011-3347. Epub 2012 Feb 8.

PMID:
22319035
15.

Growth and development: patching up a better pill for GH-deficient women.

Birzniece V, Ho KK.

Nat Rev Endocrinol. 2012 Jan 31;8(4):197-8. doi: 10.1038/nrendo.2012.9. No abstract available.

PMID:
22290355
16.

Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women.

Birzniece V, Meinhardt UJ, Gibney J, Johannsson G, Armstrong N, Baxter RC, Ho KK.

J Clin Endocrinol Metab. 2012 Mar;97(3):1005-12. doi: 10.1210/jc.2011-2837. Epub 2011 Dec 14.

PMID:
22170716
17.

Identification of novel GH-regulated pathway of lipid metabolism in adipose tissue: a gene expression study in hypopituitary men.

Zhao JT, Cowley MJ, Lee P, Birzniece V, Kaplan W, Ho KK.

J Clin Endocrinol Metab. 2011 Jul;96(7):E1188-96. doi: 10.1210/jc.2010-2679. Epub 2011 May 11.

PMID:
21565791
18.

Growth hormone and physical performance.

Birzniece V, Nelson AE, Ho KK.

Trends Endocrinol Metab. 2011 May;22(5):171-8. doi: 10.1016/j.tem.2011.02.005. Epub 2011 Mar 17. Review.

PMID:
21420315
19.

Interaction between testosterone and growth hormone on whole-body protein anabolism occurs in the liver.

Birzniece V, Meinhardt UJ, Umpleby MA, Handelsman DJ, Ho KK.

J Clin Endocrinol Metab. 2011 Apr;96(4):1060-7. doi: 10.1210/jc.2010-2521. Epub 2011 Jan 14.

PMID:
21239519
20.

Neuroendocrine regulation of growth hormone and androgen axes by selective estrogen receptor modulators in healthy men.

Birzniece V, Sata A, Sutanto S, Ho KK.

J Clin Endocrinol Metab. 2010 Dec;95(12):5443-8. doi: 10.1210/jc.2010-1477. Epub 2010 Sep 15.

PMID:
20843951
21.

Paracrine regulation of growth hormone secretion by estrogen in women.

Birzniece V, Sata A, Sutanto S, Ho KK.

J Clin Endocrinol Metab. 2010 Aug;95(8):3771-6. doi: 10.1210/jc.2010-0476. Epub 2010 May 5.

PMID:
20444909
22.

The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial.

Meinhardt U, Nelson AE, Hansen JL, Birzniece V, Clifford D, Leung KC, Graham K, Ho KK.

Ann Intern Med. 2010 May 4;152(9):568-77. doi: 10.7326/0003-4819-152-9-201005040-00007.

PMID:
20439575
23.

Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women.

Birzniece V, Meinhardt U, Gibney J, Johannsson G, Baxter RC, Seibel MJ, Ho KK.

J Clin Endocrinol Metab. 2010 May;95(5):2099-106. doi: 10.1210/jc.2009-2743. Epub 2010 Mar 5.

PMID:
20207825
24.

Growth hormone administration: is it safe and effective for athletic performance.

Birzniece V, Nelson AE, Ho KK.

Endocrinol Metab Clin North Am. 2010 Mar;39(1):11-23, vii. doi: 10.1016/j.ecl.2009.10.007.

PMID:
20122446
25.

Testosterone stimulates extra-hepatic but not hepatic fat oxidation (Fox): comparison of oral and transdermal testosterone administration in hypopituitary men.

Birzniece V, Meinhardt UJ, Handelsman DJ, Ho KK.

Clin Endocrinol (Oxf). 2009 Nov;71(5):715-21. doi: 10.1111/j.1365-2265.2009.03524.x. Epub 2009 Jan 19.

PMID:
19170715
26.

Growth hormone receptor modulators.

Birzniece V, Sata A, Ho KK.

Rev Endocr Metab Disord. 2009 Jun;10(2):145-56. doi: 10.1007/s11154-008-9089-x. Review.

PMID:
18622706
27.

GABA(A) receptor changes in acute allopregnanolone tolerance.

Birzniece V, Türkmen S, Lindblad C, Zhu D, Johansson IM, Bäckström T, Wahlström G.

Eur J Pharmacol. 2006 Mar 27;535(1-3):125-34. Epub 2006 Mar 2.

PMID:
16513107
28.

Tolerance development to Morris water maze test impairments induced by acute allopregnanolone.

Türkmen S, Löfgren M, Birzniece V, Bäckström T, Johansson IM.

Neuroscience. 2006 May 12;139(2):651-9. Epub 2006 Feb 2.

PMID:
16457954
29.

Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.

Birzniece V, Bäckström T, Johansson IM, Lindblad C, Lundgren P, Löfgren M, Olsson T, Ragagnin G, Taube M, Turkmen S, Wahlström G, Wang MD, Wihlbäck AC, Zhu D.

Brain Res Rev. 2006 Aug;51(2):212-39. Epub 2005 Dec 20. Review.

PMID:
16368148
30.

3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone.

Turkmen S, Lundgren P, Birzniece V, Zingmark E, Backstrom T, Johansson IM.

Eur J Neurosci. 2004 Sep;20(6):1604-12.

PMID:
15355327
31.

Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats.

Zhu D, Birzniece V, Bäckström T, Wahlström G.

Br J Anaesth. 2004 Oct;93(4):560-7. Epub 2004 Jul 26.

32.

Pathogenesis in menstrual cycle-linked CNS disorders.

Bäckström T, Andersson A, Andreé L, Birzniece V, Bixo M, Björn I, Haage D, Isaksson M, Johansson IM, Lindblad C, Lundgren P, Nyberg S, Odmark IS, Strömberg J, Sundström-Poromaa I, Turkmen S, Wahlström G, Wang M, Wihlbäck AC, Zhu D, Zingmark E.

Ann N Y Acad Sci. 2003 Dec;1007:42-53. Review.

PMID:
14993039
33.

The role of hormones and hormonal treatments in premenstrual syndrome.

Bäckström T, Andreen L, Birzniece V, Björn I, Johansson IM, Nordenstam-Haghjo M, Nyberg S, Sundström-Poromaa I, Wahlström G, Wang M, Zhu D.

CNS Drugs. 2003;17(5):325-42. Review.

PMID:
12665391
34.

Allopregnanolone inhibits learning in the Morris water maze.

Johansson IM, Birzniece V, Lindblad C, Olsson T, Bäckström T.

Brain Res. 2002 May 3;934(2):125-31.

PMID:
11955475
35.
36.

Serotonin 5-HT(1A) receptor mRNA expression in dorsal hippocampus and raphe nuclei after gonadal hormone manipulation in female rats.

Birzniece V, Johansson IM, Wang MD, Seckl JR, Bäckström T, Olsson T.

Neuroendocrinology. 2001 Aug;74(2):135-42.

PMID:
11474221

Supplemental Content

Loading ...
Support Center